← All South Dakota bills

HB1099Introduced in the House

Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Passed

Introduced by Tom Pischke, District 25

What does this bill do?

Plain-English breakdown

Writing a plain-English summary of this bill… this can take a few seconds the first time.

Official description

Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Where it stands

Signed by the Governor on March 10, 2026 H.J. 547

March 10, 2026

How did lawmakers vote?

House votes

2 recorded votes · each counted separately

Senate votes

2 recorded votes · each counted separately

SenateStage: Do Pass · March 2, 2026

21

Yes

12

No

2

Absent or Not Voting

35 senators recorded in this Senate vote. Colors show vote categories only, not whether a vote was good or bad.

See how each senator voted

Bill history

  1. First read in House and referred to House Health and Human Services H.J. 104

  2. Scheduled for hearing H.J. 1

  3. Health and Human Services Do Pass, Passed, YEAS 13, NAYS 0. H.J. 13

  4. House of Representatives Do Pass, Passed, YEAS 58, NAYS 7. H.J. 265

  5. First read in Senate and referred to Senate Health and Human Services S.J. 232

  6. Scheduled for hearing S.J. 1

  7. Health and Human Services Do Pass, Passed, YEAS 6, NAYS 0. S.J. 21

  8. Certified uncontested, placed on consent S.J. 21

  9. Remove from Consent Calendar S.J. 412

  10. Senate Do Pass, Passed, YEAS 21, NAYS 12. S.J. 429

  11. Signed by the Speaker H.J. 492

  12. Signed by the President S.J. 470

  13. Delivered to the Governor on March 05, 2026 H.J. 520

  14. Signed by the Governor on March 10, 2026 H.J. 547

Verify the information

Our commitment to neutrality

We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.